HaemAnalytica Showcases Next-Generation Platelet Analysis in Light of Clopidogrel Effectiveness Study
HaemAnalytica shared a noteworthy post on LinkedIn:
“It’s September, holidays are over and blood thinners are in the news! A new study has shown that clopidogrel is a more effective blood thinner than aspirin.
Our CSO, Jon Gibbins said “The impact of clopidogrel monotherapy on improved patient outcomes is very encouraging. This will improve the options available to prevent the recurrence of thrombosis. The final piece in the puzzle to provide a step-change, will be the stratification of patients – to identify which need monotherapy, which require dual anti-platelet therapy, and which are at most risk of serious bleeding side effects. This is HaemAnalytica’s mission.’”
Read the Lancet study on clopidogrel effectiveness here.
Article: Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
Authors: Marco Valgimigli, Ki Hong Choi, Daniele Giacoppo, Felice Gragnano, Takeshi Kimura, Hirotoshi Watanabe, Hyo-Soo Kim, Jeehoon Kang, Kyung Woo Park, Alf-Åge Pettersen, Mark Woodward, Deepak L Bhatt, Paolo Calabrò, Dominick J Angiolillo, Roxana Mehran, Young Bin Song, Joo-Yong Hahn
Find more on HaemAnalytica next generation platelet analysis here.
Stay updated with Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together